| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |